What we do
Our services fall in to five main categories:
Critical Insight
We provide business planning and business strategy advice to both early-stage and more developed companies. Luck may sometimes play a part in building a successful biobusiness. But it's no substitute for a well-researched and smartly executed strategy. We work with companies to develop robust business plans that provide both a compelling investment case and a solid foundation for turning a great idea in to a successful business.
Critical Intelligence
We have deep expertise in providing qualitative and quantitative market research, trends and statistical analysis of the biotech sector in Europe and beyond. Timely, reliable information is the bedrock of good decision-making for all biotech stakeholders. We provide ongoing macro-level market intelligence to government and regulatory bodies to support policy development. We provide companies with micro-level intelligence - not just the hard statistics but vital intelligence that explains what the numbers are saying in any given context.
Critical Implementation
We provide virtual business development support. This is particularly useful for early-stage companies who can't justify a full-time business development function, but who still need to develop strategic relationships or secure contracts. We work with management to identify potential strategic partners and clients, research their requirements and develop tailored pitches to suit, make the right introductions, and support management throughout the deal-making process.
Critical Investment
We help companies develop their financing strategy and identify the most appropriate investors for their needs. Knowing which investors to approach - and, equally important, who not to approach - is as important as knowing how to pitch your investment proposition to them. We work closely with the leading bioscience investors internationally. We thus have an excellent knowledge of the individuals concerned and their investment preferences - in terms of technology, company maturity, level of investment and their likely interest in acting as lead investor for particular investment propositions.
Critical Image
We provide communications advice to companies at all stages of their development. Critical I's principals have over thirty years experience in this area. First as industry commentators on the receiving end of corporate communications. Secondly, as communications advisers to both quoted and unquoted companies from across the bioscience spectrum. We help companies devise an overall communications framework which will drive their tactical investor and media relations activities.